Selective Versus Nonselective His Bundle Pacing: Does it Matter?
Selective Versus Nonselective His Bundle Pacing: Does it Matter?
复制标题
选择性与非选择性他的捆绑节奏:重要吗?
DOI:
10.1016/j.jacep.2019.05.022
复制
发表时间:
2019
期刊:
影响因子:
--
通讯作者:
K. Ellenbogen
中科院分区:
文献类型:
--
作者:
S. Padala;K. Ellenbogen
His bundle pacing (HBP) is by far the most physiological form of pacing to circumvent the deleterious effects of nonphysiological, chronic right ventricular (RV) pacing. The safety, feasibility, and superiority of HBP over RV pacing has been reported by several investigators. His bundle pacemakers have been successfully implanted in patients with normal His-Purkinje conduction, bundle branch block, atrioventricular (AV) nodal and infra-nodal block, and in selected patients as an alternative to cardiac resynchronization therapy (1–9). Despite the recent du jour, HBP lead implantation may be technically challenging due to the precise target zone and limitations of the available tools. The His bundle (HB) is a continuation of the distal part of the AV node and measures about 20 mm in length and 4 mm in diameter. Anatomically, it can be divided into 3 portions: nonpenetrating (as it passes through the annulus fibrosis); penetrating (within the fibrinous tissue of the central body and membranous septum); and branching portion (bifurcation into the left and right bundle branches at the crest of the muscular ventricular septum)(10). As such, depending on the location of the HBP lead, pacing may capture the His-Purkinje system alone, which results in a normal QRS morphology (selective HBP [S-HBP]), or the His-Purkinje system and surrounding RV myocardium, which results in a fused QRS morphology (nonselective [NS-HBP]). Although S-HBP restores the native QRS morphology and is electrocardiographically gratifying, it has been reported to be achieved in approximately one-third of the cases. In such cases, NS-HBP provides another opportunity to engage the native conduction system and may result in a relatively narrow QRS compared with RV apical pacing. However, whether the clinical outcomes differ between NS-HBP and S-HBP is unknown.In this issue of JACC: Clinical Electrophysiology, Beer et al.(11) analyzed a combined endpoint of allcause mortality or heart failure hospitalization (HFH) among 350 consecutive patients with HB pacemakers (S-HBP: n= 118; NS-HBP: n= 232) who demonstrated $20% ventricular pacing at 3 months post-implantation. Patients in the NS-HBP group had greater baseline comorbidities compared with the SHBP group, including a higher incidence of coronary artery disease, ischemic cardiomyopathy, patients in New York Heart Association functional classes III and IV, permanent atrial fibrillation, and infra-nodal block. During a mean follow-up of 1,022 days, the composite primary endpoint occurred in 36% versus 20% in the NS-HBP versus S-HBP groups, respectively (hazard ratio: 1.49; 95% confidence interval: 0.95 to 2.35; p= 0.09). The secondary endpoint of all-cause mortality occurred in 28% versus 14% in the NS-HBP versus S-HBP groups, respectively (hazard ratio: 1.65; 95% confidence interval: 0.96 to 2.86; p= 0.07). Subgroup analyses were also performed in patients who were anticipated to be at the greatest risk for the
影响因子:
5.5
作者:
Ajijola, Olujimi A.;Upadhyay, Gaurav A.;Tung, Roderick
通讯作者:
Tung, Roderick